- Home
- HIPO vs MDXG Comparison
HIPO vs MDXG Comparison
Compare HIPO & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIPO
- MDXG
- Stock Information
- Founded
- HIPO 2015
- MDXG 2006
- Country
- HIPO United States
- MDXG United States
- Employees
- HIPO N/A
- MDXG N/A
- Industry
- HIPO Property-Casualty Insurers
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- HIPO Finance
- MDXG Health Care
- Exchange
- HIPO Nasdaq
- MDXG Nasdaq
- Market Cap
- HIPO 923.0M
- MDXG 1.0B
- IPO Year
- HIPO N/A
- MDXG N/A
- Fundamental
- Price
- HIPO $32.60
- MDXG $6.83
- Analyst Decision
- HIPO Strong Buy
- MDXG Buy
- Analyst Count
- HIPO 5
- MDXG 1
- Target Price
- HIPO $35.40
- MDXG $12.00
- AVG Volume (30 Days)
- HIPO 278.3K
- MDXG 1.3M
- Earning Date
- HIPO 11-05-2025
- MDXG 10-29-2025
- Dividend Yield
- HIPO N/A
- MDXG N/A
- EPS Growth
- HIPO N/A
- MDXG N/A
- EPS
- HIPO 3.71
- MDXG 0.27
- Revenue
- HIPO $450,000,000.00
- MDXG $393,442,000.00
- Revenue This Year
- HIPO $27.93
- MDXG $19.01
- Revenue Next Year
- HIPO $22.04
- MDXG $2.36
- P/E Ratio
- HIPO $8.70
- MDXG $25.10
- Revenue Growth
- HIPO 34.41
- MDXG 14.77
- 52 Week Low
- HIPO $19.92
- MDXG $5.79
- 52 Week High
- HIPO $38.98
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- HIPO 44.00
- MDXG 44.24
- Support Level
- HIPO $31.27
- MDXG $6.45
- Resistance Level
- HIPO $34.59
- MDXG $7.51
- Average True Range (ATR)
- HIPO 2.04
- MDXG 0.32
- MACD
- HIPO -0.18
- MDXG -0.10
- Stochastic Oscillator
- HIPO 25.84
- MDXG 29.18
About HIPO Hippo Holdings Inc.
Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.